The 24 references in paper V. Moroz V., A. Golubev M., В. Мороз В, А. Голубев М (2013) “Сепсис: принципы диагностики // Sepsis: Principles of Diagnosis” / spz:neicon:reanimatology:y:2013:i:6:p:5

1
McPherson D., Griffiths C., Williams M., Baker A., Klodawski E., Jacobson B., Donaldson L.Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open.
(check this in PDF content)
2
13; 3 (8): pii: e002586. http://dx.doi.org/10.1136/bmjopen-2013002586. PMID: 23913771 2. Reed H.L., Renton S.D., Hines M.D.Dependence of all-cause standardized in-hospital mortality on sepsis mortality between 2005 and 2010. Am. J. Med. Qual.2013. http://dx.doi.org/10.1177/ 1062860613496452. PMID: 23939489
(check this in PDF content)
3
Iskander K.N., Osuchowski M.F., Stearns-Rurosawa D.J., Kurosawa S., Stepien D., Valentine C., Remick D.G.Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Phisiol. Rev. 2013; 93 (3): 1247—1288. http://dx.doi.org/10.1152/physrev.00037.2012. PMID: 23899564
(check this in PDF content)
4
Moroz V.V., Lukach V.N., Shifman E.M., Dolgikh V.T., Yakovleva I.I. Sepsis. Kliniko-patofiziologicheskie aspekty intensivnoi terapii. [Sepsis. Clinical and pathophysiological aspects of intensive therapy]. Petrozavodsk: IntelTek; 2004. [In Russ.]
(check this in PDF content)
5
Golubev A.M., Tsyganov S.E., Makedonskaya I.V.Struktura infektsionnykh oslozhnenii v otdeleniyakh reanimatsii. Materialy simpoziuma «Infektsionnye oslozhneniya v reanimatologii.» [Pattern of infectious complications in intensive care units. Proceedings of the Symposium on Infectious Complications in Reanimatology]. Moscow; 2004: 15—22. [In Russ.]
(check this in PDF content)
6
Opal S.What do we mean by sepsis? – Definitions and new paradigms. The Sepsis 2011. International Symposium 27—28 October 2011. Beijing, China; 2011.
(check this in PDF content)
7
Vincent J.-L., Opal S.M., Marshall J.C., Tracey K.Sepsis definitions: time for change. Lancet.2013; 381 (9868): 774—775. http://dx.doi.org/ 10.1016/S0140-6736(12)61815-7. PMID: 23472921
(check this in PDF content)
8
Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., Osborn T.M., Nunnally M.E., Townsend S.R., Reinhart K., Kleinpell R.M., Angus D.C., Deutschman C.S., Machado F.R., Rubenfeld G.D., Webb S.A., Beale R.J., Vincent J.-L., Moreno R.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit. Care Med.2013; 41 (2): 580—637. http://dx.doi.org/10.1097/CCM.0b013e31827e83af. PMID: 23353941
(check this in PDF content)
9
Asfar P., Claessens Y.E., Duranteau J., Kipnis E., Leone M., Levy B., Mira J.P. Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge? Ann. Intensive Care.2013; 3 (1): 27. http://dx.doi.org/10.1186/2110-5820-3-27. PMID: 23958052
(check this in PDF content)
10
Permyakov N.K.Osnovy reanimatsionnoi patologii. [Fundamentals of reanimatological pathology]. Moscow: Meditsina Publishers; 1979. [In Russ.]
(check this in PDF content)
11
Mishnev O.D., Shchegolev A.I., Trusov O.A.Patologoanatomicheskaya diagnostika sepsisa. V kn.: Sepsis v nachale XXI veka. Prakticheskoe rukovodstvo. [Pathoanatomic diagnosis of sepsis. In: Sepsis in the early 21st century. Practical guidelines]. Moscow; 2004: 111—126. [In Russ.]
(check this in PDF content)
12
Golubev A.M.Perftoran – plazmozamenitel s funktsiei transporta kisloroda. [Perfluoran is plasma substitute with oxygen transporting function]. Byulleten Eksperimentalnoi Biologii i Meditsiny.1998; 125 (5): 485—492. [In Russ.]
(check this in PDF content)
13
Magomedov S.N., Askerkhanov G.R., Golubev A.M., Ermolov A.S., Abusuev S.A., Ismailov S.A.Sposob lecheniya diabeticheskoi angiopatii. Patent RF na izobretenie RUS 2107496. [A method for treating diabetic angiopathy. RF patent for invention RUS 2107496]. [In Russ.]
(check this in PDF content)
14
Golubev A.M., Beloyartsev F.F., Vasilyev A.E., Pokrovsky Yu.E.Reaktsiya biologicheskikh system pri zameshchenii krovi emulsiyami ftoruglerodov. [Reaction of biological systems to replacement of blood with fluorocarbohydrate emulsions]. Moscow: TEIS; 1993. [In Russ.]
(check this in PDF content)
15
Ebner B., Behm P., Jacoby C., Burghoff S., French B.A., Schrader J., Flögel U.Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ. Cardiovasc. Imaging.2010; 3 (2): 202—210. http://dx.doi.org/10.1161/CIRCIMAGING.109.902312. PMID: 20061515
(check this in PDF content)
16
Srinivas M., Cruz L.J., Bonetto F., Heerschap A., Figdor C.G., de Vries J.M. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials.2010; 31 (27): 7070—7077. http://dx.doi.org/ 10.1016/j.biomaterials.2010.05.069. PMID: 20566214
(check this in PDF content)
17
Tran T.D., Caruthers S.D., Hughes M., Marsh J.N., Cyrus T., Winter P.M., Neubauer A.M., Wickline S.A., Lanza G.M.Clinical application of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int.J.Nanomedicine.2007; 2 (4): 515—526. PMID: 18203420
(check this in PDF content)
18
Flögel U., Ding Z., Hardung H., Jander S., Reichmann G., Jacoby Ch., Schubert R., Schrader J. In vivomonitoring of inflamation after cardiac and cerebral ischemia by flurine magnetic resonance imaging. Circulation.2008; 118: 140—148. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.737890. PMID: 18574049
(check this in PDF content)
19
Patel S.K., Patrick M.J., Pollock J.A., Janjic J.M.Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemulsions. J.Biomed.Opt.2013; 18 (10): 101312. http://dx.doi.org/10.1117/ 1.JBO.18.10.101312. PMID: 23912666
(check this in PDF content)
20
Walley K.R.Bomarkers in sepsis. Curr. Infect. Dis. Rep.2013; 15 (5): 413—420. http://dx.doi.org/10.1007/s11908-013-0357-x. PMID: 23975686
(check this in PDF content)
21
Burzhunova M.G., Guseva O.G., Rybakov V.Yu., Krichevsky L.A., Kozlov I.A.Informativnost natriiureticheskogo peptida B-tipa u kardiokhirurgicheskikh bolnykh s giperkreatininemiei. [The informative value of Nterminal pro-type B natriuretic peptide in cardiac surgical patients with hypercreatitinemia]. Obshchaya Reanimatologiya. 2011; 7 (6): 40–45. [In Russ.]
(check this in PDF content)
22
Moroz V.V., Perepelitsa S.A., Golubev A.M., Golubev M.A.Tsitokiny – markery immunoreaktivnosti u nedonoshennykh novorozhdennykh. [Cytokines are markers of immune responsiveness in premature neonates]. Obshchaya Reanimatologiya. 2011; 7 (5): 38–43. [In Russ.]
(check this in PDF content)
23
Prutkina E.V., Malyarchikov A.V., Tsybikov N.N., Shapovalov K.G., Isakova N.V.Rol ingibitora tkanevogo faktora plazmennoi proteinazy ADAMTS—13 i ee ingibitora v patogeneze ostrogo respiratornogo distress-sindroma pri grippe A/H1N1. [Role of a tissue factor pathway inhibitor, the plasma proteinase ADAMTS-13 and its inhibitor in the pathogenesis of acute respiratory distress syndrome in А/Н1N1 influenza. Obshchaya Reanimatologiya.2011; 7 (4): 16–19. [In Russ.]
(check this in PDF content)
24
Selivanova A.V., Yakovlev V.N., Moroz V.V., Marchenkov Yu.V., Alekseyev V.G.Izmeneniya gormonalno-metabolicheskikh pokazatelei u patsientov, nakhodyashchikhsya v kriticheskom sostoyanii. [Hormonal and metabolic changes in critically ill patients]. Obshchaya Reanimatologiya. 2012; 8 (5): 70–76. [In Russ.]
(check this in PDF content)